SSY Group (HKG:2005) obtained registration approval for Benidipine Hydrochloride from China's National Medical Products Administration to become a bulk drug for the preparations on the market, a Monday bourse filing said.
Benidipine Hydrochloride is used mainly to treat primary hypertension and angina pectoris, according to the pharmaceutical company.